Phthalazinone derivatives
US7151102B2 · kind B2 · utility
34Cited by
17References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 30, 2001 |
| Grant date | Dec 19, 2006 |
| Priority date | — |
| Expiry date | Apr 29, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treatment of a disease of the human or animal body mediated by PARP comprising administering to such a subject a therapeutically effective amount of a compound of formula:or an isomer, salt, solvate, chemically protected form, and prodrug thereof, wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.